Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001622627-24-000056
Filing Date
2024-10-23
Accepted
2024-10-23 15:14:18
Documents
2
Group Members
AHARON GILROSALIND ADVISORS, INC.ROSALIND MASTER FUND L.P.SALAMON STEVEN A J

Document Format Files

Seq Description Document Type Size
1 rosalind_bfri_13ga2_sep2.htm SC 13G/A 91790
2 rosalind_bfri_exa.htm EX-99.A BD-DIR-RESOL 2316
  Complete submission text file 0001622627-24-000056.txt   95822
Mailing Address 15 WELLESLEY STREET WEST SUITE 326 TORONTO A6 M4Y 0G7
Business Address 25 ADMIRAL ROAD TORONTO A6 M5R 2L4 4168887606
Rosalind Advisors, Inc. (Filed by) CIK: 0001622627 (see all company filings)

EIN.: 000000000 | State of Incorp.: A6 | Fiscal Year End: 1130
Type: SC 13G/A

Mailing Address 120 PRESIDENTIAL WAY, SUITE 330 WOBURN MA 01801
Business Address 120 PRESIDENTIAL WAY, SUITE 330 WOBURN MA 01801 781-245-1325
Biofrontera Inc. (Subject) CIK: 0001858685 (see all company filings)

EIN.: 473765675 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-93395 | Film No.: 241389056
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)